Biosante Pharmaceuticals Inc (NASDAQ:BPAX)

CAPS Rating: 2 out of 5

A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.

Recs

0
Player Avatar mdriver78 (< 20) Submitted: 1/12/2012 3:12:44 PM : Outperform Start Price: $0.51 BPAX Score: +115.86

Selling for less than cash!

Report this Post Reply

Featured Broker Partners


Advertisement